middle.news
How Microba’s 30% Revenue Surge Fuels UK Expansion and Diagnostic Innovation
11:40pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
How Microba’s 30% Revenue Surge Fuels UK Expansion and Diagnostic Innovation
11:40pm on Friday 29th of August, 2025 AEST
Key Points
30% revenue growth to $15.7 million in FY25
Net loss narrowed to $14.9 million from $19.9 million in FY24
Successful UK expansion through Invivo Clinical acquisition
Discontinuation of legacy products to focus on core diagnostics
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Microba Life Sciences (ASX:MAP)
OPEN ARTICLE